Viruses (Jun 2019)

Clinical Evaluation of QuickNavi<sup>TM</sup>-Ebola in the 2018 Outbreak of Ebola Virus Disease in the Democratic Republic of the Congo

  • Sheila Makiala,
  • Daniel Mukadi,
  • Anja De Weggheleire,
  • Shino Muramatsu,
  • Daisuke Kato,
  • Koichi Inano,
  • Fumio Gondaira,
  • Masahiro Kajihara,
  • Reiko Yoshida,
  • Katendi Changula,
  • Aaron Mweene,
  • Placide Mbala-Kingebeni,
  • Jean-Jacques Muyembe-Tamfum,
  • Justin Masumu,
  • Steve Ahuka,
  • Ayato Takada

DOI
https://doi.org/10.3390/v11070589
Journal volume & issue
Vol. 11, no. 7
p. 589

Abstract

Read online

The recent large outbreaks of Ebola virus disease (EVD) in West Africa and the Democratic Republic of the Congo (DRC) have highlighted the need for rapid diagnostic tests to control this disease. In this study, we clinically evaluated a previously developed immunochromatography-based kit, QuickNaviTM-Ebola. During the 2018 outbreaks in DRC, 928 blood samples from EVD-suspected cases were tested with QuickNaviTM-Ebola and the WHO-approved GeneXpert. The sensitivity and specificity of QuickNaviTM-Ebola, estimated by comparing it to GeneXpert-confirmed cases, were 85% (68/80) and 99.8% (846/848), respectively. These results indicate the practical reliability of QuickNaviTM-Ebola for point-of-care diagnosis of EVD.

Keywords